Evidence map›Paper›PMID 32075922›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Antibiotic treatment and selection for

Roger Vargas, Maha R Farhat

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phase variation as a major mechanism of adaptation inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Emergence of Canonical and Noncanonical Genomic Variants followingAntimicrobial agents and chemotherapy · 2023
    Article
  6. A critical evaluation ofMicrobial genomics · 2022
    Article
  7. Frontiers in cellular and infection microbiology · 2022
    Review
  8. Understanding the contribution of metabolism toFrontiers in cellular and infection microbiology · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  14. Heterogeneous Streptomycin Resistance Level AmongFrontiers in microbiology · 2021
    Article
  15. Reply to Vargas and Farhat:Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Roger VargasDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115; roger_vargas@g.harvard.edu.
Maha R FarhatDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115.
Center for Systems Biology · USHarvard University · US

Funding

New Tools for the interpretation of Pathogen Genomic Data with a focus on Mycobacterium tuberculosisK01ES026835 · NIEHS · MASSACHUSETTS GENERAL HOSPITAL · PI FARHAT, MAHA · 2015 to 2019
$1.1M
NIEHS NIH HHS K01 ES026835
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosisAnti-Bacterial AgentsDrug ToleranceHumansMutationAnti-Bacterial Agents

Identifiers

PMID32075922
PMCPMC7049102
OpenAlexW3008591803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.